Press Releases

ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy...

A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a return to dual supply chain strategies. The report – which summarises expert analysis into 12 key...

Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, broadens its existing partnership with Unilode Aviation Solutions, the leading provider for outsourced Unit Load Device (ULD) management and repair solutions, to meet the...

Three members of the COVID R&D Alliance - Amgen Inc., Takeda Pharmaceutical Co. Ltd. and UCB announced the first patient enrolled in the COMMUNITY Trial (COVID-19 Multiple Agents and Modulators Unified Industry Members). COMMUNITY is a randomized, double-blind, placebo-controlled,...

Eisai Co., Ltd. and Wren Therapeutics Ltd. announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery of novel small molecules that target α-synuclein for the potential treatment of synucleinopathies including Parkinson’s...

Bayer AG announced the launch of a Cell and Gene Therapy (C&GT) Platform within its Pharmaceuticals division. Through this strategic platform, the company further consolidates its emerging leadership in the field and takes a deeply transformative step for its...

DuPont Nutrition & Biosciences (DuPont) will use insights to help manufacturers evolve with the biggest trends in the Asia pharma industry, with highlights to the latest offerings at CPhI China 2020 from December 16–18. Attendees who visit DuPont booth...